Zhuhai Kerui Biotechnology: difference between revisions
Diff·revision 19 → 20·11:33, 3 Feb 2026
Difference between revision 19 and revision 20 of Zhuhai Kerui Biotechnology. 6 lines changed; the page grew by 1,086 bytes.
| Revision 19 — 05:19, 18 Jan 2026 SelectTrialSam (talk) clarify that no manufacturing or marketing authorisation is claimed or established 13,405 bytes +487 | Revision 20 — 11:33, 3 Feb 2026 ChainCustodyChad (talk) attribute the capability claim to the organisation's own material 14,491 bytes +1,086 | ||
|---|---|---|---|
| 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} |
| 93 | 93 | ||
| + | 94 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} | |
| + | 95 | ||
| 94 | == Notability and coverage == | 96 | == Notability and coverage == |
| 95 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | 97 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} |
| ⋮ | ⋮ | ||
| 97 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | 99 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} |
| 98 | 100 | ||
| + | 101 | Two frameworks are named in this article only to say what has ''not'' been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,{{r|gmp}} and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.{{r|iso17025}} Neither assessment is available here for this organisation or for any other covered on this wiki. | |
| + | 102 | ||
| 99 | == External links == | 103 | == External links == |
| 100 | * [https://keruipeptides.com/ Zhuhai Kerui Biotechnology Co., Ltd. — official site (keruipeptides.com)] — the organisation's own catalogue, stock listing and ordering pages. Marked <code>nofollow</code> and <code>sponsored</code>; PeptidePedia takes no commission and the link is not an endorsement. | 104 | * [https://keruipeptides.com/ Zhuhai Kerui Biotechnology Co., Ltd. — official site (keruipeptides.com)] — the organisation's own catalogue, stock listing and ordering pages. Marked <code>nofollow</code> and <code>sponsored</code>; PeptidePedia takes no commission and the link is not an endorsement. |
| ⋮ | ⋮ | ||
| 108 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 112 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 109 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 113 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| + | 114 | <ref name="iso17025">ISO/IEC 17025:2017, ''General requirements for the competence of testing and calibration laboratories''. International Organization for Standardization.</ref> | |
| 110 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 115 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 116 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 111 | 117 | ||
| 112 | == Further reading == | 118 | == Further reading == |